This inventor holds 5 USPTO granted patents. Top assignees: The Mclean Hospital Corporation, Northeastern University, Other. Active years: 1987-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1987-2011
Title: Ross J Baldessarini: Innovator in Pharmacology
Introduction
Ross J Baldessarini is a prominent inventor based in Newton, MA (US). He has made significant contributions to the field of pharmacology, particularly in the development of treatments for various neurological and psychological disorders. With a total of 5 patents to his name, Baldessarini's work has had a profound impact on medical science.
Latest Patents
Among his latest patents are two notable inventions:
1. R(−)-11-hydroxyaporphine derivatives and uses thereof - This invention features derivatives of R(−)-11-hydroxyaporphines and methods of treating Parkinson's disease, sexual dysfunction, and depressive disorders.
2. R(—)-11-hydroxyaporphine derivatives and uses thereof - Similar to the first, this invention also focuses on derivatives of R(—)-11-hydroxyaporphines and their applications in treating Parkinson's disease, sexual dysfunction, and depressive disorders.
Career Highlights
Baldessarini has had a distinguished career, working with reputable institutions such as McLean Hospital Corporation and Northeastern University. His research has been pivotal in advancing our understanding of various mental health conditions and their treatments.
Collaborations
Throughout his career, Baldessarini has collaborated with esteemed colleagues, including John L Neumeyer and Alexander S Campbell. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
In summary, Ross J Baldessarini is a notable inventor whose work in pharmacology has led to significant advancements in the treatment of neurological and psychological disorders. His contributions continue to influence the field and improve the lives of many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile